Clinical Trials

Can Nature's Peptides Defeat Melanoma Drug Resistance?
Research & Development Can Nature's Peptides Defeat Melanoma Drug Resistance?

The fight against advanced melanoma, a particularly aggressive form of skin cancer, has long been hindered by the cancer's ability to develop resistance to conventional treatments. However, a groundbreaking study led by QUT researchers at Brisbane's Translational Research Institute (TRI) offers a

Cognitive Shortcomings of AI Chatbots in Dementia Screening Tests
Tech & Innovation Cognitive Shortcomings of AI Chatbots in Dementia Screening Tests

Recent research has delved into the cognitive limitations of large language models (LLMs), or "chatbots," when subjected to dementia screening tests traditionally used on humans. The study, published in the Christmas issue of The BMJ, reveals that almost all leading LLMs exhibit signs of mild

Factors Influencing Participation in COVID-19 Vaccine Trials
Research & Development Factors Influencing Participation in COVID-19 Vaccine Trials

The COVID-19 pandemic presented a global challenge, with governments and health institutions striving to contain the virus amid misinformation and rapid transmission. One pivotal approach was the development of various COVID-19 vaccine trials, employing adaptive methods to expedite recruitment

Can Patient-Centered Design Transform Clinical Trial Spaces?
Research & Development Can Patient-Centered Design Transform Clinical Trial Spaces?

Clinical trials are essential for advancing medical research and developing new treatments. However, one of the significant challenges faced by clinical trials is patient enrollment. According to GlobalData, over half of clinical trial failures are due to enrollment problems. Patients often feel

Does 5-FU Fight Cancer by Targeting RNA Instead of DNA?
Research & Development Does 5-FU Fight Cancer by Targeting RNA Instead of DNA?

5-Fluorouracil (5-FU) has been a cornerstone in cancer treatment for decades, primarily believed to work by damaging DNA and preventing cancer cells from replicating. However, recent research suggests that 5-FU's primary mechanism of action may be through targeting RNA, particularly ribosomal RNA,

Pocketalk Device Enhances Communication with Non-English Patients
Tech & Innovation Pocketalk Device Enhances Communication with Non-English Patients

The trial of handheld translation devices in a network of eight GP surgeries in Southampton has demonstrated impressive results, paving the way for improved communication with 5,850 non-English-speaking patients. This innovative trial spanned several months, from April 2024 to August 2024, and was

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later